Literature DB >> 25248587

Nonfunctioning pituitary tumors.

Mark E Molitch1.   

Abstract

Clinically nonfunctioning adenomas range from being completely asymptomatic, and therefore detected either at autopsy or as incidental findings on head MRI or CT scans performed for other reasons, to causing significant hypothalamic/pituitary dysfunction and visual field compromise due to their large size. Patients with incidental adenomas should be screened for hypersecretion (prolactin, insulin-like growth factor 1, midnight salivary cortisol) and for hypopituitarism (macroadenomas). In the absence of hypersecretion, hypopituitarism, or visual field defects, patients may be followed by periodic screening by MRI for enlargement, at which point surgery may be necessary. Symptomatic patients with clinically nonfunctioning adenomas are generally treated by transsphenoidal surgery. Postoperative MRIs are done at 3-4 months after surgery to assess for completeness of resection and then repeated yearly for 3-5 years and subsequently less frequently to assess for regrowth. For those with no visible tumor on MRI, the tumor regrowth rate is about 13% and such patients may be followed with periodic MRIs. For those with visible tumor, the tumor regrowth rate is about 40%. This regrowth rate may be substantially reduced with the use of dopamine agonists and radiotherapy.
© 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenoma; nonfunctioning; pituitary; radiotherapy; transsphenoidal; tumor; “incidentaloma”

Mesh:

Year:  2014        PMID: 25248587     DOI: 10.1016/B978-0-444-59602-4.00012-5

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  15 in total

1.  Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors.

Authors:  Weipeng Xiong; Christopher J Matheson; Mei Xu; Donald S Backos; Taylor S Mills; Smita Salian-Mehta; Katja Kiseljak-Vassiliades; Philip Reigan; Margaret E Wierman
Journal:  Mol Cancer Ther       Date:  2015-12-31       Impact factor: 6.261

2.  Outcome of pituitary hormone deficits after surgical treatment of nonfunctioning pituitary macroadenomas.

Authors:  Orsalia Alexopoulou; Valérie Everard; Martine Etoa; Edward Fomekong; Stéphane Gaillard; Fabrice Parker; Christian Raftopoulos; Philippe Chanson; Dominique Maiter
Journal:  Endocrine       Date:  2021-04-14       Impact factor: 3.633

3.  Clinical Course of Nonfunctional Pituitary Microadenoma in Children: A Single-Center Experience.

Authors:  Vidhu V Thaker; Adrianne E Lage; Garima Kumari; V Michelle Silvera; Laurie E Cohen
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

Review 4.  Management of nonfunctioning pituitary adenomas (NFAs): observation.

Authors:  Wenyu Huang; Mark E Molitch
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

5.  Growth of Pituitary Macroadenomas Postpartial Resection: Implications for Adjuvant Radiotherapy.

Authors:  Valerie Panet-Raymond; Kushraw Sabit; George Shenouda; Denis Sirhan; Anthony Zeitouni; Luis Souhami
Journal:  J Neurol Surg B Skull Base       Date:  2018-10-10

6.  Usefulness of an ad hoc questionnaire (Acro-CQ) for the systematic assessment of acromegaly comorbidities at diagnosis and their management at follow-up.

Authors:  F Guaraldi; D Gori; G Beccuti; N Prencipe; R Giordano; Y Mints; V S Di Giacomo; A Berton; M Lorente; V Gasco; E Ghigo; R Salvatori; S Grottoli
Journal:  J Endocrinol Invest       Date:  2016-05-06       Impact factor: 4.256

Review 7.  Headaches in Patients with Pituitary Tumors: a Clinical Conundrum.

Authors:  Laura E Donovan; Mary R Welch
Journal:  Curr Pain Headache Rep       Date:  2018-07-04

8.  Mammalian Ste20-like kinase 4 promotes pituitary cell proliferation and survival under hypoxia.

Authors:  Weipeng Xiong; Aaron J Knox; Mei Xu; Katja Kiseljak-Vassiliades; Sean P Colgan; Kelley S Brodsky; Bette K Kleinschmidt-Demasters; Kevin O Lillehei; Margaret E Wierman
Journal:  Mol Endocrinol       Date:  2015-02-04

Review 9.  Management of NFAs: medical treatment.

Authors:  Naomi Even-Zohar; Yona Greenman
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

10.  Geographic-Related Differences of Pituitary Adenomas Hormone Profile: Analysis of Two Groups Coming from Southeastern and Eastern Europe.

Authors:  Anca Maria Cimpean; Eugen Melnic; Bogdan Bălinişteanu; Ana Corlan; Mihail Coculescu; Sergiu Rusu; Marius Raica
Journal:  Int J Endocrinol       Date:  2015-05-11       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.